You can Subscribe to our RSS FEED: which delivers brain tumor news and additions to the website via RSS.
Click HERE for details on RSS.
Displaying items 801 to 825 of about 5897
Next 25
11/22/2020
CRISPR-Cas9 genome editing using targeted lipid nanoparticles for cancer therapy
DNAtrix Announces Positive Data from Phase 2 CAPTIVE (KEYNOTE-192) Study with DNX-2401 in Patients with Recurrent Glioblastoma Highlighted in an Oral Late-Breaking Presentation During Society for Neuro-oncology (SNO) Annual Meeting
11/20/2020
PLUS THERAPEUTICS ANNOUNCES POSITIVE INTERIM DATA FROM RESPECTâ„¢ PHASE 1 CLINICAL TRIAL IN RECURRENT GLIOBLASTOMA
11/19/2020
Novocure Announces 43 Presentations on Tumor Treating Fields at Society for Neuro-Oncology 2020 Virtual Annual Meeting
NX Development Corp. (NXDC) Launches Gleolan (aminolevulinic acid HCl) Meningioma Phase III Clinical Trial (NXDC-MEN-301)
11/17/2020
xCures launches xACCESS - A new module in their AI-assisted clinical platform
PLUS THERAPEUTICS ANNOUNCES WEBINAR TO PRESENT RESPECTâ„¢ GLIOBLASTOMA CLINICAL TRIAL UPDATE
OncoSynergy Opens Enrollment for Clinical Trial of New Cancer Antibody Therapy, OS2966, in Patients with Recurrent Glioblastoma
11/15/2020
Clinical Characteristics of High-Grade Glioma with Primary Leptomeningeal Seeding at Initial Diagnosis in a Single Center Study
11/13/2020
GT Medical Technologies Announces First Patient Treated in Registry Trial of GammaTile Therapy for Brain Tumors
11/12/2020
Novocure: A Disruptive Growth Play In Cancer Treatments
11/10/2020
Feasibility of Treating High Grade Gliomas in Children with Tumor-Treating Fields: A Case Series
11/05/2020
First Patient Treated With Experimental Therapy For Deadly Childhood Brain Cancer
Oncoceutics Receives Foundation Grants to Establish an Expanded Access Program for ONC201
11/04/2020
ANNOUNCING THE LAUNCH OF OUR NEW WEBSITE AND CHANGE OF DOMAIN NAME FROM .Com to .Org
Problem With News Blast Yesterday
11/03/2020
Clinical efficacy and predictive biomarkers of ONC201 in H3 K27M-mutant diffuse midline glioma
11/02/2020
The Man Behind The Musella Foundation
10/29/2020
Musella Foundation Accomplishments
Alpha-type-1 Polarized Dendritic Cell-based Vaccination in Newly Diagnosed High-grade Glioma: A Phase II Clinical Trial
10/26/2020
Evolution of radiotherapies for brain tumors - the story of GammaTile Therapy.
10/19/2020
Midatech Pharma PLC Announces Headline Results of MTX110 Phase I DIPG Study
10/15/2020
Musella Foundation Copayment Assistance Program Closed to New patients
10/08/2020
What would YOU do if you were diagnosed with GBM?
10/04/2020
Brain TUmor Webinar Tonight!